Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / EBS - Chimerix ticks higher on new order for smallpox therapy

EBS - Chimerix ticks higher on new order for smallpox therapy

Emergent Biosolutions Inc.
The shares of Chimerix (NASDAQ:CMRX) rose on Friday after the company announced that Public Health Agency of Canada awarded it a contract to deliver up to $25.3M of Tembexa (brincidofovir), a treatment approved in the U.S. for smallpox. On Thursday, Chimerix (CMRX) announced an agreement with an entity outside of North America to deliver $9.3M worth of Tembexa. The latest deals coincide with an ongoing outbreak of monkeypox, a virus related to smallpox. Chimerix (CMRX) said that the execution of the latest deal is expected to substantially occur before the completion of its recent announced agreement with Emergent BioSolutions (EBS). This month, Emergent (EBS) signed a deal to acquire the exclusive worldwide rights for brincidofovir including Tembexa from Chimerix (CMRX) for up to $325M and royalties.

For further details see:

Chimerix ticks higher on new order for smallpox therapy
Stock Information
Company Name: Emergent Biosolutions Inc.
Stock Symbol: EBS
Market: NYSE
Website: emergentbiosolutions.com
Menu
EBS EBS Quote EBS Short EBS News EBS Articles EBS Message Board
Get EBS Alerts

News, Short Squeeze, Breakout and More Instantly...